1. Home
  2. IMAX vs TMDX Comparison

IMAX vs TMDX Comparison

Compare IMAX & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imax Corporation

IMAX

Imax Corporation

HOLD

Current Price

$53.31

Market Cap

2.4B

Sector

N/A

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$88.40

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMAX
TMDX
Founded
1967
1998
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.6B
IPO Year
1997
2019

Fundamental Metrics

Financial Performance
Metric
IMAX
TMDX
Price
$53.31
$88.40
Analyst Decision
Strong Buy
Buy
Analyst Count
10
9
Target Price
$44.50
$148.22
AVG Volume (30 Days)
1.8M
975.9K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
31.25
382.18
EPS
0.35
0.61
Revenue
$410,212,000.00
$605,494,000.00
Revenue This Year
$9.79
$24.25
Revenue Next Year
$7.51
$18.75
P/E Ratio
$151.09
$145.21
Revenue Growth
16.47
37.13
52 Week Low
$25.48
$60.11
52 Week High
$54.27
$156.00

Technical Indicators

Market Signals
Indicator
IMAX
TMDX
Relative Strength Index (RSI) 72.32 64.49
Support Level $34.27 $66.64
Resistance Level N/A $152.95
Average True Range (ATR) 1.87 4.31
MACD 0.38 1.16
Stochastic Oscillator 90.95 92.03

Price Performance

Historical Comparison
IMAX
TMDX

About IMAX Imax Corporation

Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: